Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19

HTx consortium members at National Institute for Health and Care Excellence (NICE), UK, NHS England and NHS Improvement, UK, National Health Care Institute (Zorginstituut Nederland), Netherlands, Syreon Research Institute, Hungary and Utrecht University, the Netherlands, with the help of experts from all around the world, developed a best practice guidance to provide a set of consistent, pragmatic ways for HTA agencies to approach some of the key challenges they are likely to face when assessing COVID-19 technologies.
The guidance aims to give HTA agencies recommendations with which they can hopefully provide more timely, robust, evidence-based decisions about the value of COVID-19 technologies and seek to ensure efficient, affordable care for COVID-19 going forward. Further, this guidance should improve pandemic preparedness, providing a blueprint for HTA agencies to rapidly support decision making in response to a future pandemic.
To read more about the publication, click here and read our press release READ THE PRESS RELEASE
To read the full publication, click HERE